Research and Innovation

Interfarma 16/10/26

Patent is fundamental to encourage innovation and does not mean monopoly

Interfarma 16/10/26

The balance of innovation between competition law and intellectual property

Interfarma 16/10/26

Intellectual property advances in the country, but needs to become State policy

Interfarma 16/10/26

INPI’s delay in analyzing patents may lead to action to extend the deadline

Interfarma 16/10/26

Companies manage to adjust the patent term in court

Interfarma 16/10/26

INPI backlog improvement is still insufficient and hinders innovation

Interfarma 16/10/26

Second-use patents return to the debate after Anvisa’s public consultation